Year |
Citation |
Score |
2015 |
Çelik H, Sajwan KP, Selvanathan SP, Marsh BJ, Pai AV, Kont YS, Han J, Minas TZ, Rahim S, Erkizan HV, Toretsky JA, Üren A. Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level. Molecular and Cellular Biology. 35: 3145-62. PMID 26149384 DOI: 10.1128/Mcb.00332-15 |
0.574 |
|
2015 |
Simbulan-Rosenthal CM, Gaur A, Sanabria VA, Dussan LJ, Saxena R, Schmidt J, Kitani T, Chen YS, Rahim S, Uren A, Crooke E, Rosenthal DS. Inorganic polyphosphates are important for cell survival and motility of human skin keratinocytes. Experimental Dermatology. PMID 25869331 DOI: 10.1111/Exd.12729 |
0.516 |
|
2015 |
Celik H, Sajwan KP, Pai AV, Marsh BJ, Kont YS, Rahim S, Han J, Minas T, Toretsky JA, Uren A. Abstract 3269: Ezrin binds to DEAD-box RNA helicase DDX3 and regulates its function and protein level Cancer Research. 75: 3269-3269. DOI: 10.1158/1538-7445.Am2015-3269 |
0.529 |
|
2014 |
Rahim S, Minas T, Hong SH, Justvig S, Çelik H, Kont YS, Han J, Kallarakal AT, Kong Y, Rudek MA, Brown ML, Kallakury B, Toretsky JA, Üren A. A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model. Plos One. 9: e114260. PMID 25479232 DOI: 10.1371/Journal.Pone.0114260 |
0.66 |
|
2014 |
Tosso PN, Kong Y, Scher L, Cummins R, Schneider J, Rahim S, Holman KT, Toretsky J, Wang K, Ãœren A, Brown ML. Synthesis and structure-activity relationship studies of small molecule disruptors of EWS-FLI1 interactions in Ewing's sarcoma. Journal of Medicinal Chemistry. 57: 10290-303. PMID 25432018 DOI: 10.1021/Jm501372P |
0.41 |
|
2014 |
Paige M, Kosturko G, Bulut G, Miessau M, Rahim S, Toretsky JA, Brown ML, Üren A. Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma. Bioorganic & Medicinal Chemistry. 22: 478-87. PMID 24326277 DOI: 10.1016/J.Bmc.2013.11.003 |
0.608 |
|
2014 |
Rahim S, Justvig S, Hong S, Tosso P, Celik H, Sayedigar-Kont Y, Brown M, Morrissey C, Toretsky J, Üren A. Abstract 2949: YK-4-279 is a small molecule inhibitor of ETV1 and inhibits metastasis in a mouse model Cancer Research. 74: 2949-2949. DOI: 10.1158/1538-7445.Am2014-2949 |
0.707 |
|
2013 |
Rahim S, Uren A. Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer. American Journal of Translational Research. 5: 254-68. PMID 23634237 |
0.638 |
|
2013 |
Rahim S, Justvig S, Hong S, Kong Y, Brown ML, Morrissey C, Toretsky JA, Uren A. Abstract 5453: YK-4-279 inhibits ETS-positive prostate cancer cell metastasis in a mouse xenograft model. Cancer Research. 73: 5453-5453. DOI: 10.1158/1538-7445.Am2013-5453 |
0.693 |
|
2012 |
Briggs JW, Ren L, Nguyen R, Chakrabarti K, Cassavaugh J, Rahim S, Bulut G, Zhou M, Veenstra TD, Chen Q, Wei JS, Khan J, Uren A, Khanna C. The ezrin metastatic phenotype is associated with the initiation of protein translation. Neoplasia (New York, N.Y.). 14: 297-310. PMID 22577345 DOI: 10.1593/Neo.11518 |
0.651 |
|
2012 |
Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene. 31: 269-81. PMID 21706056 DOI: 10.1038/Onc.2011.245 |
0.718 |
|
2011 |
Rahim S, Beauchamp EM, Kong Y, Brown ML, Toretsky JA, Üren A. YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion. Plos One. 6: e19343. PMID 21559405 DOI: 10.1371/Journal.Pone.0019343 |
0.714 |
|
2011 |
Rahim S, Üren A. A real-time electrical impedance based technique to measure invasion of endothelial cell monolayer by cancer cells. Journal of Visualized Experiments : Jove. PMID 21490581 DOI: 10.3791/2792 |
0.592 |
|
2011 |
Rahim S, Beauchamp EM, Kong Y, Brown ML, Toretsky JA, Üren A. Abstract 663: YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion Cancer Research. 71: 663-663. DOI: 10.1158/1538-7445.Am2011-663 |
0.735 |
|
2011 |
Bulut G, Hong S, Chen K, Rahim S, Kosturko GW, Beauchamp EM, Glasgow E, Toretsky JA, Khanna C, Uren A. Abstract 4505: Development of small molecules to target ezrin as anti-metastatic agents Cancer Research. 71: 4505-4505. DOI: 10.1158/1538-7445.Am2011-4505 |
0.725 |
|
Show low-probability matches. |